Laura Bernal

Laura Bernal, PhD, currently serves as a Medical Advisor in Specialty Care and Rare Disease at Pfizer, with a background that includes roles such as MSL and Rare Disease Medical Affairs Trainee. Laura possesses extensive experience in product development stages, offering scientific support to internal stakeholders. In addition to contributions at Pfizer, Laura is a member of Nova Talent and BioExpert Network, and serves on the NeuPSIG Trainee Subcommittee. Previous research endeavors include identifying drug targets for polyneuropathy and inflammatory bowel disease at Universidad de Alcalá and conducting R&D at Eli Lilly and Company focused on in vitro drug screening. Laura holds multiple advanced degrees, including a PhD from Universidad de Alcalá and a Master's in Neuroscience from Universidad Autónoma de Madrid, complemented by business qualifications in Medical Affairs and Big Data.